Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies

Chin Med J (Engl). 2023 Jan 20;136(2):230-232. doi: 10.1097/CM9.0000000000002556.
No abstract available

Publication types

  • Letter

MeSH terms

  • Asthma* / drug therapy
  • Biological Therapy*
  • Humans